Dr. Melissa Davis
Honorary
Medical Biology (w.e.h.i.)
92 Scholarly works
1 Projects
HIGHLIGHTS
2021
Journal article
Dissection of the bone marrow microenvironment in hairy cell leukaemia identifies prognostic tumour and immune related biomarkers
DOI: 10.1038/s41598-021-98536-12021
Journal article
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
DOI: 10.1126/sciadv.abf44082021
Journal article
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
DOI: 10.1186/s13073-021-00920-z2021
Journal article
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
DOI: 10.1038/s41590-021-00943-z2020
Journal article
Cotargeting BCL-2 and MCL-1 in high-risk B-ALL
DOI: 10.1182/bloodadvances.20190014162020
Journal article
An Erg-driven transcriptional program controls B cell lymphopoiesis.
DOI: 10.1038/s41467-020-16828-y2014
Research Grant
CASS Travel Grant
RECENT SCHOLARLY WORKS
2021
Journal article
Measuring pathway database coverage of the phosphoproteome
DOI: 10.7717/peerj.112982021
Journal article
Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype
DOI: 10.1038/s41467-021-22888-52021
Journal article
Measuring and Modelling the Epithelial- Mesenchymal Hybrid State in Cancer: Clinical Implications
DOI: 10.1159/0005152892021
Journal article
PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
DOI: 10.1186/s13073-021-00871-52021
Journal article
Type 2 Innate Lymphoid Cells Protect against Colorectal Cancer Progression and Predict Improved Patient Survival
DOI: 10.3390/cancers130305592020
Journal article
Eukaryote-ConservedMethylarginine Is Absent in Diplomonads and Functionally Compensated in Giardia
DOI: 10.1093/molbev/msaa186